269 related articles for article (PubMed ID: 19368899)
21. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
[TBL] [Abstract][Full Text] [Related]
22. Social skills and neurocognitive individualized training in schizophrenia: comparison with structured leisure activities.
Galderisi S; Piegari G; Mucci A; Acerra A; Luciano L; Rabasca AF; Santucci F; Valente A; Volpe M; Mastantuono P; Maj M
Eur Arch Psychiatry Clin Neurosci; 2010 Jun; 260(4):305-15. PubMed ID: 19826855
[TBL] [Abstract][Full Text] [Related]
23. BDNF serum levels are not related to cognitive functioning in older depressed patients and controls.
Dols A; Thesing CS; Bouckaert F; Oude Voshaar RC; Comijs HC; Stek ML
Int Psychogeriatr; 2015 Apr; 27(4):649-56. PubMed ID: 25519687
[TBL] [Abstract][Full Text] [Related]
24. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
25. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
[TBL] [Abstract][Full Text] [Related]
26. A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia.
Niitsu T; Ishima T; Yoshida T; Hashimoto T; Matsuzawa D; Shirayama Y; Nakazato M; Shimizu E; Hashimoto K; Iyo M
Psychiatry Res; 2014 Feb; 215(2):268-73. PubMed ID: 24377440
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia.
Song X; Fan X; Li X; Kennedy D; Pang L; Quan M; Chen X; Gao J; Zhang W; Zhang J; Lv L
Schizophr Res; 2014 Oct; 159(1):51-5. PubMed ID: 25128453
[TBL] [Abstract][Full Text] [Related]
28. Association between increased serum d-serine and cognitive gains induced by intensive cognitive training in schizophrenia.
Panizzutti R; Fisher M; Garrett C; Man WH; Sena W; Madeira C; Vinogradov S
Schizophr Res; 2019 May; 207():63-69. PubMed ID: 29699895
[TBL] [Abstract][Full Text] [Related]
29. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
Pirildar S; Gönül AS; Taneli F; Akdeniz F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
[TBL] [Abstract][Full Text] [Related]
30. Effects of antipsychotics on the serum BDNF levels in schizophrenia.
Chen CC; Huang TL
Psychiatry Res; 2011 Oct; 189(3):327-30. PubMed ID: 21320726
[TBL] [Abstract][Full Text] [Related]
31. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study.
Aydemir O; Deveci A; Taneli F
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):261-5. PubMed ID: 15694233
[TBL] [Abstract][Full Text] [Related]
32. Auditory Cortical Plasticity Drives Training-Induced Cognitive Changes in Schizophrenia.
Dale CL; Brown EG; Fisher M; Herman AB; Dowling AF; Hinkley LB; Subramaniam K; Nagarajan SS; Vinogradov S
Schizophr Bull; 2016 Jan; 42(1):220-8. PubMed ID: 26152668
[TBL] [Abstract][Full Text] [Related]
33. Smartphone video games improve cognitive function in patients with chronic schizophrenia: a randomized controlled trial.
Shi S; Cui S; Yao Y; Ge M; Yang M; Sheng X; Luo B; Yang Y; Yuan X; Zhou X; Liu H; Zhang K
Eur Arch Psychiatry Clin Neurosci; 2024 Jun; 274(4):929-939. PubMed ID: 37594510
[TBL] [Abstract][Full Text] [Related]
34. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
Rizos EN; Michalopoulou PG; Siafakas N; Stefanis N; Douzenis A; Rontos I; Laskos E; Kastania A; Zoumpourlis V; Lykouras L
Neuropsychobiology; 2010; 62(2):87-90. PubMed ID: 20523079
[TBL] [Abstract][Full Text] [Related]
35. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
[TBL] [Abstract][Full Text] [Related]
36. Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients.
Heitz U; Papmeyer M; Studerus E; Egloff L; Ittig S; Andreou C; Vogel T; Borgwardt S; Graf M; Eckert A; Riecher-Rössler A
World J Biol Psychiatry; 2019 Sep; 20(7):545-554. PubMed ID: 29938562
[No Abstract] [Full Text] [Related]
37. Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan SP; Hui L; Lv MH; Soares JC; Zhang XY
Psychopharmacology (Berl); 2015 Jan; 232(1):223-32. PubMed ID: 24994553
[TBL] [Abstract][Full Text] [Related]
38. Exercise Induced Neuroplasticity to Enhance Therapeutic Outcomes of Cognitive Remediation in Schizophrenia: Analyzing the Role of Brai nderived Neurotrophic Factor.
Campos C; Rocha NBF; Lattari E; Nardi AE; Machado S
CNS Neurol Disord Drug Targets; 2017; 16(6):638-651. PubMed ID: 28017130
[TBL] [Abstract][Full Text] [Related]
39. Differential Effects of Physical Exercise, Cognitive Training, and Mindfulness Practice on Serum BDNF Levels in Healthy Older Adults: A Randomized Controlled Intervention Study.
Ledreux A; Håkansson K; Carlsson R; Kidane M; Columbo L; Terjestam Y; Ryan E; Tusch E; Winblad B; Daffner K; Granholm AC; Mohammed AKH
J Alzheimers Dis; 2019; 71(4):1245-1261. PubMed ID: 31498125
[TBL] [Abstract][Full Text] [Related]
40. An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.
Pawełczyk T; Grancow-Grabka M; Trafalska E; Szemraj J; Żurner N; Pawełczyk A
Psychopharmacology (Berl); 2019 Sep; 236(9):2811-2822. PubMed ID: 31098654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
